Back to Search Start Over

The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.

Authors :
Helgadottir A
Manolescu A
Thorleifsson G
Gretarsdottir S
Jonsdottir H
Thorsteinsdottir U
Samani NJ
Gudmundsson G
Grant SF
Thorgeirsson G
Sveinbjornsdottir S
Valdimarsson EM
Matthiasson SE
Johannsson H
Gudmundsdottir O
Gurney ME
Sainz J
Thorhallsdottir M
Andresdottir M
Frigge ML
Topol EJ
Kong A
Gudnason V
Hakonarson H
Gulcher JR
Stefansson K
Source :
Nature genetics [Nat Genet] 2004 Mar; Vol. 36 (3), pp. 233-9. Date of Electronic Publication: 2004 Feb 08.
Publication Year :
2004

Abstract

We mapped a gene predisposing to myocardial infarction to a locus on chromosome 13q12-13. A four-marker single-nucleotide polymorphism (SNP) haplotype in this locus spanning the gene ALOX5AP encoding 5-lipoxygenase activating protein (FLAP) is associated with a two times greater risk of myocardial infarction in Iceland. This haplotype also confers almost two times greater risk of stroke. Another ALOX5AP haplotype is associated with myocardial infarction in individuals from the UK. Stimulated neutrophils from individuals with myocardial infarction produce more leukotriene B4, a key product in the 5-lipoxygenase pathway, than do neutrophils from controls, and this difference is largely attributed to cells from males who carry the at-risk haplotype. We conclude that variants of ALOX5AP are involved in the pathogenesis of both myocardial infarction and stroke by increasing leukotriene production and inflammation in the arterial wall.

Details

Language :
English
ISSN :
1061-4036
Volume :
36
Issue :
3
Database :
MEDLINE
Journal :
Nature genetics
Publication Type :
Academic Journal
Accession number :
14770184
Full Text :
https://doi.org/10.1038/ng1311